GLOBEALERT
SCI & TECH● LOW1h ago · Oct 24, 2026, 6:03 PM

Zymeworks early-stage results on ADC show anti-tumor activity in ovarian cancer

Seeking Alpha Tech · global

Zymeworks has reported early-stage results for an ADC showing anti-tumor activity in ovarian cancer. This indicates potential progress in cancer treatment research.

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

More in Sci & Tech